The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors

Hamid Mahdizadeh. et al • BMC Cancer 2025/5/27

Intra‐lesion injection of activated Natural Killer (NK) cells in recurrent malignant brain tumors

Niloufar Shayan. et al • International Immunopharmacology 2023/7/1

Hsp70, in combination with IL‐15 and PD‐1 blocker, interferes with the induction of cytotoxic NK cells in relapsed acute myeloid leukemia patients

Javad Firouzi. et al • Cell Journal (Yakhteh) 2023/2/14

Overcoming the UCB HSCs–derived NK cells dysfunction through harnessing RAS/MAPK, IGF‐1R and TGF‐β signaling pathways

Alireza Shokouhifar. et al • Cancer Cell International 2021/6/7

HSP70/IL‐2 treated NK cells effectively cross the blood brain barrier and target tumor cells in a rat model of induced glioblastoma multiforme (GBM)

Farzaneh Sharifzad. et al • International Journal of Molecular Sciences 2020/3/25

Neuropathological and genomic characterization of glioblastoma‐induced rat model: How similar is it to humans for targeted therapy?

Farzaneh Sharifzad. et al • Journal of Cellular Physiology 2019/12

Glioblastoma cancer stem cell biology: Potential theranostic targets

Farzaneh Sharifzad. et al • Drug Resistance Updates 2019/1/1